Corbus Pharmaceuticals, Inc.

110 articles about Corbus Pharmaceuticals, Inc.

• Corbus Expands Clinical Development Of Resunab With A Phase 2 Trial For The Treatment Of Rare Disease Dermatomyositis

  6/8/2015

• Corbus Announces Presentation Of Positive Data On Resunab In Pre-Clinical Models Of Cystic Fibrosis At The 2015 Cystic Fibrosis Foundation Research Conference

  6/2/2015

• Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow

  5/29/2015

• Corbus Receives FDA Clearance To Initiate Phase 2 Clinical Study of Resunab For The Treatment Of Cystic Fibrosis

  5/18/2015

• Corbus Reports 2015 First Quarter Financial Results And Provides Business Update

  5/14/2015

• Corbus Appoints Charles N. Serhan, Ph.D., To Scientific Advisory Board

  5/14/2015

• Tiny Corbus Looks to Give Vertex Some Competition With Experimental Cystic Fibrosis Drug

  5/6/2015

• Corbus To Present At The Cystic Fibrosis Workshop Hosted By JMP Securities On May 8, 2015

  5/5/2015

• Corbus Pharmaceuticals, Inc. Receives $5 Million Development Award From Cystic Fibrosis Foundation Therapeutics To Advance Resunab Clinical Program

  4/24/2015

• Corbus Pharmaceuticals, Inc. Announces Initiation Of Trading On The Nasdaq Capital Market

  4/17/2015

• Corbus Pharmaceuticals, Inc. To Ring The Nasdaq Stock Market Closing Bell

  4/16/2015

• Corbus Pharmaceuticals, Inc. Announces Uplisting To The NASDAQ Capital Market

  4/15/2015

• Corbus Pharmaceuticals, Inc. Announces Presentation Of Positive Data On Anti-Fibrotic Effects Of Resunab In A Preclinical Model Of Lung Fibrosis At The Experimental Biology 2015 Scientific Conference

  4/1/2015

• Corbus Pharmaceuticals, Inc.' IND Receives Clearance From FDA To Initiate Phase 2 Trials In Scleroderma With Its Novel Specialized Pro-Resolving Mediator Drug Resunab

  3/9/2015

• Corbus Pharmaceuticals, Inc. Observes Annual Rare Disease Day

  3/2/2015

• Corbus Pharmaceuticals, Inc. To Present At The Leerink Global Healthcare Conference On February 11, 2015

  2/12/2015

• Corbus Pharmaceuticals, Inc. Reports 2014 Financial Results And Provides 2015 Business Update

  2/11/2015

• Corbus Pharmaceuticals, Inc. To Present At The 17th Annual BIO CEO & Investor Conference On February 9, 2015

  2/2/2015

• Corbus Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences

  1/8/2015

• Corbus Pharmaceuticals, Inc. To Present At Oppenheimer 25th Annual Healthcare Conference On December 10, 2014

  12/5/2014